Stonegate Capital Partners has initiated coverage on Nu Skin Enterprises Inc. $(NUS)$. The company reported strong Q2 results with revenue at the high end of its guidance range and adjusted EPS significantly exceeding expectations. Notable growth was seen in the Rhyz Manufacturing segment and Latin America. More details can be found at newsfilecorp.com/release/176254.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.